Natco Pharma rises on launching Pomalidomide capsules with Breckenridge Pharmaceutical

Natco Pharma rises on launching Pomalidomide capsules with Breckenridge Pharmaceutical

Mumbai, March 4 (Udaipur Kiran): Natco Pharma is currently trading at Rs. 965.00, up by 8.60 points or 0.90% from its previous closing of Rs. 956.40 on the BSE. The scrip opened at Rs. 955.05 and has touched a high and low of Rs. 992.00 and Rs. 955.05 respectively. So far 196763 shares were traded … Read more

Natco Pharma jumps on getting CDSCO’s approval for Semaglutide Injection in India

Natco Pharma rises on launching Pomalidomide capsules with Breckenridge Pharmaceutical

Mumbai, February 16 (Udaipur Kiran): Natco Pharma is currently trading at Rs. 885.35, up by 63.25 points or 7.69% from its previous closing of Rs. 822.10 on the BSE. The scrip opened at Rs. 825.05 and has touched a high and low of Rs. 895.00 and Rs. 825.05 respectively. So far 382 shares were traded … Read more

Natco Pharma gets USFDA’s tentative approval for Trabectedin for Injection

natco pharma surges on getting eir from usfda for api facility in hyderabad

Natco Pharma has received tentative approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Trabectedin for Injection (generic for Yondelis ) for the 1mg/vial presentation. According to industry sales data, Yondelis generated annual sales of $49.7 million for the twelve months ending June 2022 in the US … Read more

Natco Pharma jumps on launching first generic version of Revlimid along with Arrow International in US market

natco pharma surges on getting eir from usfda for api facility in hyderabad

Natco Pharma is currently trading at Rs. 857.80, up by 13.50 points or 1.60% from its previous closing of Rs. 844.30 on the BSE. The scrip opened at Rs. 880.00 and has touched a high and low of Rs. 920.00 and Rs. 849.10 respectively. So far 63843 shares were traded on the counter. The BSE … Read more

Natco Pharma gains on getting nod for Molnupiravir Capsules for Covid-19 treatment in India

natco pharma surges on getting eir from usfda for api facility in hyderabad

Natco Pharma is currently trading at Rs. 899.10, up by 8.65 points or 0.97% from its previous closing of Rs. 890.45 on the BSE. The scrip opened at Rs. 900.00 and has touched a high and low of Rs. 910.00 and Rs. 895.30 respectively. So far 12163 shares were traded on the counter. The BSE … Read more

BREAKING NEWS:
Top 6 Bowlers Who Conceded Most Sixes in IPL 2026 Chahal tops, Bhuvneshwar beats Bumrah in T20 wickets! “New Aadhaar Rule: Easy Complaint for DOB Update Failures”